CD274 and hepatocellular carcinoma: Additionally, the over-expression of immune checkpoint genes, such as PD-L1, CTLA-4, LAG3, and TIM3, has been frequently correlated with unfavorable prognosis in HCC patients, with high levels of PD-L1 expression particularly indicative of a diminished response to immunotherapy [4].